Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2025)

Axsome Therapeutics (AXSM) has disclosed Amortization - Intangibles for 4 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Amortization - Intangibles changed 0.0% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, changed 0.27% year-over-year, with the annual reading at $6.4 million for FY2025, 0.27% changed from the prior year.
  • Amortization - Intangibles hit $1.6 million in Q4 2025 for Axsome Therapeutics, roughly flat from $1.6 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $1.6 million in Q3 2022 to a low of $926000.0 in Q2 2022.
  • Historically, Amortization - Intangibles has averaged $1.6 million across 4 years, with a median of $1.6 million in 2024.
  • Biggest five-year swings in Amortization - Intangibles: skyrocketed 71.6% in 2023 and later dropped 1.07% in 2025.
  • Year by year, Amortization - Intangibles stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025.
  • Business Quant data shows Amortization - Intangibles for AXSM at $1.6 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.